Profile data is unavailable for this security.
About the company
Indoco Remedies Limited is an India-based fully integrated, research-oriented pharmaceutical company. The Company develops and manufactures a range of pharmaceutical products for the Indian and international markets. In the international market, it has tie-ups with generic companies across the globe. It has approximately eight domestic marketing divisions, with a brand portfolio in various therapeutic segments including gastro-intestinal, respiratory, anti-infective, stomatologicals, ophthalmic, nutritionals, cardiovascular, anti-diabetics, pain management, gynecology and others. The Company's brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Aloja, Glychek, Kidodent, Subitral and Rexidin. The Company has around 11 manufacturing facilities, seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs), supported by a research and development center and a clinical research organization facility.
- Revenue in INR (TTM)18.22bn
- Net income in INR766.90m
- Incorporated1947
- Employees5.93k
- LocationIndoco Remedies Ltd166 Indoco HouseCst Road, Santacruz EastMUMBAI 400098IndiaIND
- Phone+91 2 226541851
- Fax+91 2 226523980
- Websitehttps://www.indoco.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amrutanjan Health Care Ltd | 4.27bn | 425.73m | 23.16bn | 635.00 | 54.50 | -- | 47.43 | 5.42 | 14.71 | 14.71 | 147.56 | -- | -- | -- | -- | 6,726,040.00 | -- | 16.22 | -- | 20.12 | 49.61 | 53.09 | 9.97 | 13.23 | -- | 212.51 | -- | 18.95 | 10.96 | 10.71 | 12.90 | 12.46 | 26.93 | 16.43 |
Themis Medicare Ltd | 4.08bn | 500.16m | 26.29bn | 1.54k | 52.60 | -- | 42.64 | 6.44 | 5.43 | 5.43 | 44.31 | -- | -- | -- | -- | 2,648,322.00 | -- | 11.12 | -- | 16.46 | 63.51 | 60.32 | 12.26 | 14.96 | -- | -- | -- | 7.59 | 7.74 | 15.75 | -23.51 | -- | 26.73 | -- |
IOL Chemicals and Pharmaceuticals Ltd. | 20.72bn | 1.19bn | 28.56bn | 2.78k | 24.08 | -- | 15.45 | 1.38 | 20.20 | 20.20 | 353.05 | -- | -- | -- | -- | 7,461,253.00 | -- | 14.91 | -- | 19.45 | 33.96 | 34.54 | 5.72 | 12.00 | -- | 10.06 | -- | 10.59 | -3.80 | 4.82 | -3.39 | -10.70 | 35.27 | -- |
Dishman Carbogen Amcis Ltd | 24.16bn | -2.48bn | 29.99bn | 1.13k | -- | -- | 173.66 | 1.24 | -15.81 | -15.81 | 154.06 | -- | -- | -- | -- | 21,344,260.00 | -- | -0.3986 | -- | -0.4888 | 79.30 | 73.83 | -10.27 | -1.54 | -- | -0.7216 | -- | -- | 8.41 | 4.91 | -414.93 | -- | -0.3175 | -- |
SMS Pharmaceuticals Ltd | 7.38bn | 569.64m | 31.19bn | 1.20k | 54.60 | -- | 35.06 | 4.22 | 6.75 | 6.75 | 87.48 | -- | -- | -- | -- | 6,168,549.00 | -- | 5.43 | -- | 7.33 | 30.12 | 33.30 | 7.69 | 7.87 | -- | 4.21 | -- | 6.17 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
Solara Active Pharma Sciences Ltd | 13.00bn | -5.61bn | 32.18bn | 2.16k | -- | -- | -- | 2.48 | -143.75 | -143.75 | 334.17 | -- | -- | -- | -- | 6,030,149.00 | -- | -2.44 | -- | -3.84 | 37.34 | 41.16 | -43.17 | -4.49 | -- | -1.57 | -- | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 34.52bn | 1.23k | -- | 109.19 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
Indoco Remedies Ltd | 18.22bn | 766.90m | 34.76bn | 5.93k | 45.73 | -- | 19.96 | 1.91 | 8.25 | 8.25 | 178.33 | -- | -- | -- | -- | 3,072,462.00 | -- | 6.88 | -- | 9.85 | 68.61 | 65.59 | 4.10 | 6.93 | -- | 2.95 | -- | 14.02 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
RPG Life Sciences Limited | 6.00bn | 923.20m | 37.18bn | 1.27k | 40.27 | -- | 33.66 | 6.20 | 55.82 | 55.82 | 362.60 | -- | -- | -- | -- | 4,721,969.00 | -- | 16.07 | -- | 21.77 | 68.42 | 62.99 | 15.39 | 11.99 | -- | 220.43 | -- | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
Gufic BioSciences Ltd | 8.14bn | 863.69m | 40.72bn | 1.45k | 46.69 | -- | 39.36 | 5.00 | 8.70 | 8.70 | 81.95 | -- | -- | -- | -- | 5,624,707.00 | -- | 11.46 | -- | 19.21 | 52.39 | 45.79 | 10.60 | 10.46 | -- | 8.09 | -- | 1.31 | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
SeQuent Scientific Ltd | 14.27bn | 54.87m | 43.22bn | 1.20k | 811.76 | -- | 55.64 | 3.03 | 0.2137 | 0.2137 | 57.18 | -- | -- | -- | -- | 11,939,190.00 | -- | 1.09 | -- | 1.76 | 45.38 | 41.97 | 0.9902 | 1.18 | -- | 0.9009 | -- | 35.06 | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
Innova Captab Ltd | 11.42bn | 1.06bn | 45.49bn | -- | 33.55 | -- | 36.61 | 3.98 | 23.69 | 23.69 | 236.62 | -- | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 33.38 | 25.18 | 9.30 | 8.04 | -- | 8.89 | -- | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
Unichem Laboratories Ltd | 17.28bn | -605.50m | 45.49bn | 3.19k | -- | -- | 87.07 | 2.63 | -8.59 | -8.59 | 245.15 | -- | -- | -- | -- | 5,410,587.00 | -- | -1.67 | -- | -2.03 | 62.00 | 56.18 | -3.50 | -3.99 | -- | 0.1401 | -- | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
Morepen Laboratories Ltd | 17.45bn | 1.18bn | 47.32bn | 1.62k | 37.37 | -- | 31.62 | 2.71 | 2.31 | 2.31 | 34.26 | -- | -- | -- | -- | 10,749,300.00 | -- | 7.90 | -- | 13.34 | 37.86 | 33.34 | 6.77 | 5.49 | -- | 33.34 | -- | 0.00 | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
Holder | Shares | % Held |
---|---|---|
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Aug 2024 | 4.58m | 4.97% |
quant Money Managers Ltd.as of 30 Aug 2024 | 4.20m | 4.56% |
DSP Asset Managers Pvt. Ltd.as of 31 Aug 2024 | 2.30m | 2.49% |
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Aug 2024 | 1.39m | 1.51% |
Franklin Templeton Asset Management (India) Pvt Ltd.as of 30 Aug 2024 | 1.36m | 1.48% |
ICICI Prudential Asset Management Co. Ltd.as of 31 Aug 2024 | 1.22m | 1.32% |
Dimensional Fund Advisors LPas of 05 Sep 2024 | 631.89k | 0.69% |
Tata Asset Management Pvt Ltd.as of 31 Aug 2024 | 276.85k | 0.30% |
Fiduciary Management, Inc.as of 30 Jun 2024 | 165.42k | 0.18% |
Motilal Oswal Asset Management Co. Ltd.as of 31 Aug 2024 | 74.60k | 0.08% |